 | Up a level |
Anderson, Simon D, Hobbs, Robert J, Gwenin, Vanessa V, Ball, Patrick, Bennie, Lindsey A, Coulter, Jonathan A and Gwenin, Chris D 
ORCID: 0000-0003-0363-8168
(2019)
Cell-Penetrating Peptides as a Tool for the Cellular Uptake of a Genetically Modified Nitroreductase for use in Directed Enzyme Prodrug Therapy.
JOURNAL OF FUNCTIONAL BIOMATERIALS, 10 (4).
E45-.
Ball, Patrick, Halliwell, Jennifer, Anderson, Simon, Gwenin, Vanessa and Gwenin, Christopher ORCID: 0000-0003-0363-8168
(2020)
Evaluation of two xenobiotic reductases from<i>Pseudomonas putida</i>for their suitability for magnetic nanoparticle-directed enzyme prodrug therapy as a novel approach to cancer treatment.
MICROBIOLOGYOPEN, 9 (10).
e1110-.
Ball, Patrick, Thompson, Emma, Anderson, Simon, Gwenin, Vanessa and Gwenin, Chris ORCID: 0000-0003-0363-8168
(2019)
Time dependent HPLC analysis of the product ratio of enzymatically reduced prodrug CB1954 by a modified and immobilised nitroreductase.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 127.
pp. 217-224.
Ball, Patrick, Hobbs, Robert, Anderson, Simon, Thompson, Emma, Gwenin, Vanessa, Von Ruhland, Christopher and Gwenin, Christopher ORCID: 0000-0003-0363-8168
(2021)
The YfkO Nitroreductase from Bacillus Licheniformis on Gold-Coated Superparamagnetic Nanoparticles: Towards a Novel Directed Enzyme Prodrug Therapy Approach.
PHARMACEUTICS, 13 (4).
517-.
Ball, Patrick, Thompson, Emma, Anderson, Simon, Gwenin, Vanessa, Ashoorzadeh, Amir, Smaill, Jeff and Gwenin, Chris ORCID: 0000-0003-0363-8168
(2023)
The dinitrobenzamide mustard prodrugs, PR-104A and SN27686, for use in a novel MNDEPT cancer prodrug therapy approach.
BIOSCIENCE REPORTS, 43 (4).
BSR20230627-.